IWIN — Irwin Naturals Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Irwin Naturals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 87.9 | 89.4 | 100 | 89.5 |
| Cost of Revenue | ||||
| Gross Profit | 39 | 36.5 | 44.7 | 40.7 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 81.5 | 81.7 | 92.3 | 90.9 |
| Operating Profit | 6.36 | 7.66 | 8.06 | -1.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 5.99 | 7.36 | 7.93 | -0.97 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 5.92 | 7.24 | 10.1 | -2.52 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 5.92 | 7.24 | 8.62 | -3.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 5.92 | 7.24 | 8.62 | -3.99 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.019 | 0.017 | 0.033 | -1.32 |